News and Trends 29 Jun 2023
FDA gives Orphan Drug Designation to CellCentric multiple myeloma drug
CellCentric, a UK-based biotechnology company, has announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for inobrodib in the treatment of multiple myeloma. Delivered as…